Clinical trial
Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or…
NCT00090974 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00090974 |
|---|---|
| Title | Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer |
| Official title | Quality Of Life Companion Study For JMA27 (NCIC-MA.27): A Randomized Phase III Trial Of Exemestane Versus Anastrozole With Or Without Celecoxib In Postmenopausal Women With Receptor Positive Primary Breast Cancer |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH NCIC Clinical Trials Group |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer |
| Intervention type | Procedure |
| Interventions | quality-of-life assessment |
| Start date | Jan 26, 2005 |
| Primary completion | Jan 30, 2013 |
| Completion | Jan 30, 2013 |
| First posted | Sep 8, 2004 |
| Last update posted | Jun 15, 2023 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: